McClellan William D. Jr.

Director at REATA PHARMACEUTICALS INC

Sold, on record
$2.1M
Dollars the filings state
Form 4 sales
3
Latest Jul 28, 2023
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale REATA PHARMACEUTICALS INCUnusual
    Nov 9, 2020 2020

    Sold 4,000 shares at $150.01 ($600k)

    McClellan William D. Jr., Director

    Sold 100% of holdings ($600k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale REATA PHARMACEUTICALS INCUnusual
    Nov 12, 2020 +3 days

    Sold 4,000 shares at $172.92 ($692k)

    McClellan William D. Jr., Director

    Sold 100% of holdings ($692k position)0 shares leftFiling

  3. 3 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Jul 28, 2023 +988 days

    Filed to sell 5,000 shares ($822k)

    McClellan William D. Jr., Director

    10b5-1 planFirst sale on recordFiling

  4. 4 Form 4 sale REATA PHARMACEUTICALS INCRoutine
    Jul 28, 2023 same day

    Sold 5,000 shares at $164.49 ($822k)

    McClellan William D. Jr., Director

    10b5-1 planSold 45.4% of holdings ($1.8M position)6,017 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by McClellan William D. Jr.
Source
Jul 28, 2023Aug 1, 2023REATA PHARMACEUTICALS INCDirectorForm 4 sale5,000$822k45.4%RoutineSEC
Jul 28, 2023Jul 28, 2023REATA PHARMACEUTICALS INCDirectorForm 144 notice5,000$822kNoticeSEC
Nov 12, 2020Nov 13, 2020REATA PHARMACEUTICALS INCDirectorForm 4 sale4,000$692k100.0%UnusualSEC
Nov 9, 2020Nov 10, 2020REATA PHARMACEUTICALS INCDirectorForm 4 sale4,000$600k100.0%UnusualSEC